胚系CSF3R杂合变异是血液系统恶性肿瘤的风险等位基因
研究通过832次二代测序检测分析632例血液系统恶性肿瘤患者,鉴定CSF3R为新胚系血液恶性肿瘤易感基因。3个胚系CSF3R变异在功能测试中异常,p.Trp547*导致功能缺失,p.Ala119Thr降低G-CSF敏感性,p.Pro784Thr抑制受体内化产生功能获得性表型。胚系CSF3R杂合变异是髓系和淋系恶性肿瘤的风险因素。
要点
- 胚系CSF3R杂合变异是血液恶性肿瘤新易感因素。
- p.Trp547*为功能缺失变异,降低CSF3R表达和G-CSF反应。
- p.Pro784Thr为功能获得性变异,导致G-CSF超敏。
核心结论
- 胚系CSF3R杂合变异是髓系和淋系恶性肿瘤发生的风险因素。
研究设计与样本
- 对632例血液系统恶性肿瘤患者进行832次二代测序检测,分析胚系CSF3R变异。
主要发现
- 3个胚系CSF3R变异在功能测试中异常,提示有害。
- p.Trp547*见于2例分别在76岁和33岁诊断的骨髓增生异常综合征无关男性。
- p.Ala119Thr见于1例多发性骨髓瘤和1例急性淋巴细胞白血病患者。
- p.Pro784Thr见于1例67岁多发性骨髓瘤男性。
关键数值与推荐
- p.Trp547*为细胞外域无义变异,降低CSF3R mRNA表达,消除表面表达和G-CSF增殖反应。
- p.Ala119Thr位于细胞外免疫球蛋白样和细胞因子受体同源域之间,降低G-CSF敏感性。
- p.Pro784Thr为胞质域错义变异,抑制CSF3R内化,产生功能获得性表型和G-CSF超敏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colony-stimulating factor 3 receptor (CSF3R) encodes the receptor for granulocyte colony-stimulating factor (G-CSF), a cytokine vital for granulocyte proliferation and differentiation. Acquired activating heterozygous variants in CSF3R are the main cause of chronic neutrophilic leukemia, a hyperproliferative disorder. In contrast, biallelic germ line hypomorphic variants in CSF3R are a rare cause of severe congenital neutropenia, a hypoproliferative condition. The impact of heterozygous germ line CSF3R variants, however, is unknown. We identified CSF3R as a new germ line hematologic malignancy predisposition gene through analysis of 832 next-generation sequencing tests conducted in 632 patients with hematologic malignancies. Among germ line CSF3R variants, 3 were abnormal in functional testing, indicating their deleterious nature. p.Trp547* was identified in 2 unrelated men with myelodysplastic syndromes diagnosed at 76 and 33 years of age, respectively. p.Trp547* is a loss-of-function nonsense variant in the extracellular domain that results in decreased CSF3R messenger RNA expression and abrogation of CSF3R surface expression and proliferative responses to G-CSF. p.Ala119Thr is a missense variant found in 2 patients with multiple myeloma and acute lymphoblastic leukemia, respectively. This variant is located between the extracellular immunoglobulin-like and cytokine receptor homology domains and results in decreased G-CSF sensitivity. p.Pro784Thr was identified in a 67-year-old man with multiple myeloma. p.Pro784Thr is a missense variant in the cytoplasmic domain that inhibits CSF3R internalization, producing a gain-of-function phenotype and G-CSF hypersensitivity. Our findings identify germ line heterozygous CSF3R variants as risk factors for development of myeloid and lymphoid malignancies.
引用
- Trottier AM, Druhan LJ, Kraft IL, et al. Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies. Blood Adv. 2020. PMID: 33108454. doi:10.1182/bloodadvances.2020002013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。